Pages that link to "Q42498073"

The following pages link to Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia (Q42498073):

Displaying 41 items.

• A study of cytokeratin 20 immunostaining in the urothelium of neuropathic bladder of patients with spinal cord injury (Q24800928) (← links)
• Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies (Q30444665) (← links)
• Immunocytochemical characterisation of cultures of human bladder mucosal cells (Q33874538) (← links)
• Relationship of PCNA, C-erbB2 and CD44s expression with tumor grade and stage in urothelial carcinomas of the bladder (Q33911085) (← links)
• Diagnostic utility of p53 and CK20 immunohistochemical expression grading urothelial malignancies. (Q33991812) (← links)
• Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens (Q35075808) (← links)
• The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement? (Q35192387) (← links)
• Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth (Q35555875) (← links)
• Karyometry detects subvisual differences in chromatin organisation state between non-recurrent and recurrent papillary urothelial neoplasms of low malignant potential (Q35588153) (← links)
• The 2004 WHO classification of bladder tumors: a summary and commentary (Q36111995) (← links)
• Association of Cytokeratin and Vimentin Protein in the Genesis of Transitional Cell Carcinoma of Urinary Bladder Patients (Q36320307) (← links)
• Bladder cancer: clinical and pathological profile (Q37278983) (← links)
• Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies (Q37397581) (← links)
• When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression (Q37933675) (← links)
• Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinoma (Q38031649) (← links)
• The relationship of cancer stem cells in urological cancers (Q38202644) (← links)
• Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal-like urothelial cells: an immunohistochemical and histopathogenetic study. (Q38390445) (← links)
• Evaluation of cytokeratin-19 & cytokeratin-20 and interleukin-6 in Egyptian bladder cancer patients (Q38989368) (← links)
• In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival (Q39028041) (← links)
• Characterization of Epithelial Progenitors in Normal Human Palatine Tonsils and Their HPV16 E6/E7-Induced Perturbation (Q40925848) (← links)
• The Effects of Instrumentation on Urine Cytology and CK-20 Analysis for the Detection of Bladder Cancer (Q41593022) (← links)
• Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens (Q41839758) (← links)
• Minichromosome maintenance complex component 7 has an important role in the invasion of papillary urothelial neoplasia (Q42365278) (← links)
• Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance (Q44395602) (← links)
• Bladder cancer: epidemiology, staging and grading, and diagnosis. (Q45247416) (← links)
• Differentiation of human endometrial stem cells into urothelial cells on a three-dimensional nanofibrous silk-collagen scaffold: an autologous cell resource for reconstruction of the urinary bladder wall (Q46057054) (← links)
• Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs. (Q46833964) (← links)
• Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome. (Q52963664) (← links)
• Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder. (Q53297019) (← links)
• Long‐term outcome of bladder papillary urothelial neoplasms of low malignant potential (Q53297454) (← links)
• Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. (Q53312517) (← links)
• Glycoprotein-130 expression is associated with aggressive bladder cancer and is a potential therapeutic target (Q58089982) (← links)
• Pathobiology of cigarette smoke-induced invasive cancer of the renal pelvis and its prevention by vitamin C (Q58583131) (← links)
• Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression (Q59489830) (← links)
• Transcriptional Analysis of Immunohistochemically Defined Subgroups of Non-Muscle-Invasive Papillary High-Grade Upper Tract Urothelial Carcinoma (Q64274457) (← links)
• [The 2004 WHO classification of bladder tumors: a summary and commentary] (Q80652807) (← links)
• [Urinary bladder tumours. The new 2004 WHO classification] (Q81141036) (← links)
• Molecular markers in the diagnostics and therapy of urothelial cancer (Q85225296) (← links)
• Isolation and multipotential differentiation of mesenchymal stromal cell‑like progenitor cells from human bladder (Q93090366) (← links)
• CK14 Expression Identifies a Basal/Squamous-Like Type of Papillary Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (Q94547018) (← links)
• Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer (Q94569112) (← links)